Trodelvy (Sacituzumab Govitecan-Hziy Vials) 180mg

Trodelvy (sacituzumab govitecan-hziy) is an FDA-approved therapy for metastatic triple-negative breast cancer. This 180mg vial form supports targeted cancer treatment under medical supervision. Explore Trodelvy uses and handling guidance here.

Strength

180mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Gilead sciences ,Inc,USA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trodelvy is used to treat metastatic triple-negative breast cancer in adults who have received at least two prior therapies. It targets cancer cells using a combination of chemotherapy and antibody delivery. This medication is designed for patients whose cancer has spread beyond the breast or lymph nodes. It is prescribed when other treatments have not been effective.

Side Effects

Trodelvy works by delivering chemotherapy directly to cancer cells while sparing healthy tissue. Patients may experience changes in energy levels or appetite during treatment. Some report temporary digestive effects or skin sensitivity. These responses vary widely among individuals.

Precautions & Warnings

Store Trodelvy vials refrigerated between 2–8°C and protect from light. Handle with care to avoid contamination or spills. Use only as directed by a healthcare professional. Dispose of unused medication properly according to local guidelines.

Avoid Interactions

Trodelvy may interact with strong CYP3A4 inhibitors or inducers, affecting its metabolism. Avoid live vaccines during treatment due to potential immune response interference. Discuss all medications, including over-the-counter and supplements, with your doctor before starting Trodelvy.

Frequently Asked Questions

Trodelvy is used to treat metastatic triple-negative breast cancer in adults after prior therapies.

Trodelvy is given as an intravenous infusion by a healthcare provider in a clinical setting.

Common effects may include fatigue, nausea, or low blood cell counts; report persistent issues to your doctor.

No, Trodelvy must be administered under medical supervision in a healthcare facility.

Yes, Trodelvy combines a chemotherapy agent with a targeted antibody for cancer treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.